Humacyte Inc.

NASDAQ: HUMA · Real-Time Price · USD
1.91
0.03 (1.60%)
At close: Aug 15, 2025, 3:47 PM

Humacyte Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.02 -2.65 -18.17 -10.94
PEG Ratio
-0.23 -0.00 0.22 0.12
PS Ratio
n/a n/a 138.94 229.44
PB Ratio
-11.36 21.68 1.86 2.37
P/FCF Ratio
-6 -3.89 -3.01 -3.56
P/OCF Ratio
-6.1 -4.01 -3.06 -3.57
OCF/S Ratio
n/a n/a -45.45 -64.28
Debt / Equity Ratio
-0.31 4.29 0.43 0.42
Quick Ratio
2.40 4.52 7.88 20.75
Current Ratio
2.40 4.52 7.88 20.75
Asset Turnover
n/a n/a 0.01 0.00
Interest Coverage
-12.33 -15.16 -13.64 -18.68
Return on Equity
2.82 -8.18 -0.1 -0.22
Return on Assets
-1.08 -0.86 -0.06 -0.09
Return on Invested Capital
-0.94 -0.87 -0.43 -0.29
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -4.27 -47.57
Net Profit Margin
n/a n/a -7.65 -20.96
Pretax Profit Margin
n/a n/a -7.65 -20.96
Operating Profit Margin
n/a n/a -54.04 -64.3
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -48.8 -57.77